Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer

13Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Dual probes that possess positron emission tomography (PET) and fluorescence imaging (FI) capabilities are precision medicine tools that can be used to improve patient care and outcomes. Detecting tumor lesions using PET, an extremely sensitive technique, coupled with fluorescence-guided surgical resection of said tumor lesions can maximize the removal of cancerous tissue. The development of novel molecular probes is important for targeting different biomarkers as every individual case of cancer has different characteristics. This short review will discuss some aspects of dual PET/FI probes and explore the recently reported examples.

Cite

CITATION STYLE

APA

Yuen, R., West, F. G., & Wuest, F. (2022, March 1). Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer. Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics14030645

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free